Codeine is a pain reliever that is used to treat mild to moderate pain. It belongs to the class of drugs known as narcotic analgesics (pain medicines). To treat pain, this drug operates on the central nervous system (CNS).
In Denmark and the United Kingdom, codeine was removed from
three combination formulations supplied legally without a medical prescription
from licenced pharmacies. The codeine was extracted using Internet-based
tampering procedures. Liquid chromatography and tandem mass spectrometry
(LC–MS/MS) were used to determine the quantities of codeine and non-opioid
analgesics in tampered items.
In the near future, strict rules in key regions for codeine formulation are projected to be a major factor limiting the codeine market's growth. In Australia, for example, the Therapeutic Goods Administration reclassified codeine, which was formerly available over-the-counter, as a prescription-only pharmaceutical in February 2018. The reason for this categorization was that long-term usage of codeine-containing medications can lead to addiction.
This Codeine research report has a lot of details that will
help you find the proper settings and give you useful information. The study
examines the business sector in depth, including market size, competitive
landscape, growth trends, product utilisation, growth prospects by region,
application possibilities, and other variables. The data for this research
study was gathered through primary and secondary research. Consumer behaviour,
brand positioning, pricing analysis, and key player strategies are all examined
in depth in this Codeine report. The research study includes a market overview
based on data from industry experts, key players, trade organisations, and
industry groups.